Nordic healthcare and biotech growth capital investor KDev Investments, jointly owned by Karolinska Development and Rosetta Capital, has sold its stake in Swedish pharmaceutical research business Inhalation Sciences to Råsunda Förvaltning.
Standout Capital holds 55% of the shares, while former owners retain a 45% stake in the company
Deal marks a partial sale for the US-based private equity house after a three-year holding period
Postgraduate student loans company also secured a $200m debt facility as part of the deal
Fundraising figures from unquote" data point towards a record year for UK-based managers, following the post-crisis peak reached in 2016